Maria Muravyeva1, Ines Baotic, Martin Bienengraeber, Jozef Lazar, Zeljko J Bosnjak, Filip Sedlic, David C Warltier, Judy R Kersten. 1. From the Department of Anesthesiology (M.M., I.B., M.B., Z.J.B., F.S., D.C.W., and J.R.K.), Department of Pharmacology and Toxicology (M.B., D.C.W., and J.R.K.), and Department of Physiology (Z.J.B.), Medical College of Wisconsin, Milwaukee, Wisconsin; and The Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin (J.L.).
Abstract
BACKGROUND: Diabetes alters mitochondrial bioenergetics and consequently disrupts cardioprotective signaling. The authors investigated whether mitochondrial DNA (mtDNA) modulates anesthetic preconditioning (APC) and cardiac susceptibility to ischemia-reperfusion injury by using two strains of rats, both sharing nuclear genome of type 2 diabetes mellitus (T2DN) rats and having distinct mitochondrial genomes of Wistar and fawn-hooded hypertensive (FHH) rat strains (T2DN(mtWistar) and T2DN(mtFHH), respectively). METHODS: Myocardial infarct size was measured in Wistar, T2DN(mtWistar), and T2DN(mtFHH) rats with or without APC (1.4% isoflurane) in the presence or absence of antioxidant N-acetylcysteine. Flavoprotein fluorescence intensity, a marker of mitochondrial redox state, 5-(and-6)-chloromethyl-2',7'-dichlorofluorescein fluorescence intensity, a marker of reactive oxygen species generation, and mitochondrial permeability transition pore opening were assessed in isolated rat ventricular cardiomyocytes with or without isoflurane (0.5 mmol/l). RESULTS: Myocardial infarct size was decreased by APC in Wistar and T2DN(mtWistar) rats (to 42 ± 6%, n = 8; and 44 ± 7%, n = 8; of risk area, respectively) compared with their respective controls (60 ± 3%, n = 6; and 59 ± 9%, n = 7), but not in T2DN(mtFHH) rats (60 ± 2%, n = 8). N-acetylcysteine applied during isoflurane treatment restored APC in T2DN(mtFHH) (39 ± 6%, n = 7; and 38 ± 5%, n = 7; 150 and 75 mg/kg N-acetylcysteine, respectively), but abolished protection in control rats (54 ± 8%, n = 6). Similar to the data on infarct size, APC delayed mitochondrial permeability transition pore opening in T2DN(mtWistar) but not in T2DN(mtFHH) cardiomyocytes. Isoflurane increased flavoprotein and 5-(and-6)-chloromethyl-2',7'-dichlorofluorescein fluorescence intensity in all rat strains, with the greatest effect in T2DN(mtFHH) cardiomyocytes. CONCLUSION: Differences in the mitochondrial genome modulate isoflurane-induced generation of reactive oxygen species which translates into differential susceptibility to APC and ischemia-reperfusion injury in diabetic rats.
BACKGROUND:Diabetes alters mitochondrial bioenergetics and consequently disrupts cardioprotective signaling. The authors investigated whether mitochondrial DNA (mtDNA) modulates anesthetic preconditioning (APC) and cardiac susceptibility to ischemia-reperfusion injury by using two strains of rats, both sharing nuclear genome of type 2 diabetes mellitus (T2DN) rats and having distinct mitochondrial genomes of Wistar and fawn-hooded hypertensive (FHH) rat strains (T2DN(mtWistar) and T2DN(mtFHH), respectively). METHODS:Myocardial infarct size was measured in Wistar, T2DN(mtWistar), and T2DN(mtFHH) rats with or without APC (1.4% isoflurane) in the presence or absence of antioxidant N-acetylcysteine. Flavoprotein fluorescence intensity, a marker of mitochondrial redox state, 5-(and-6)-chloromethyl-2',7'-dichlorofluorescein fluorescence intensity, a marker of reactive oxygen species generation, and mitochondrial permeability transition pore opening were assessed in isolated rat ventricular cardiomyocytes with or without isoflurane (0.5 mmol/l). RESULTS:Myocardial infarct size was decreased by APC in Wistar and T2DN(mtWistar) rats (to 42 ± 6%, n = 8; and 44 ± 7%, n = 8; of risk area, respectively) compared with their respective controls (60 ± 3%, n = 6; and 59 ± 9%, n = 7), but not in T2DN(mtFHH) rats (60 ± 2%, n = 8). N-acetylcysteine applied during isoflurane treatment restored APC in T2DN(mtFHH) (39 ± 6%, n = 7; and 38 ± 5%, n = 7; 150 and 75 mg/kg N-acetylcysteine, respectively), but abolished protection in control rats (54 ± 8%, n = 6). Similar to the data on infarct size, APC delayed mitochondrial permeability transition pore opening in T2DN(mtWistar) but not in T2DN(mtFHH) cardiomyocytes. Isoflurane increased flavoprotein and 5-(and-6)-chloromethyl-2',7'-dichlorofluorescein fluorescence intensity in all rat strains, with the greatest effect in T2DN(mtFHH) cardiomyocytes. CONCLUSION: Differences in the mitochondrial genome modulate isoflurane-induced generation of reactive oxygen species which translates into differential susceptibility to APC and ischemia-reperfusion injury in diabeticrats.
Authors: Franz Kehl; John G Krolikowski; Boris Mraovic; Paul S Pagel; David C Warltier; Judy R Kersten Journal: Anesthesiology Date: 2002-01 Impact factor: 7.892
Authors: Katsuya Tanaka; Franz Kehl; Weidong Gu; John G Krolikowski; Paul S Pagel; David C Warltier; Judy R Kersten Journal: Am J Physiol Heart Circ Physiol Date: 2002-06 Impact factor: 4.733
Authors: Lynda M Ludwig; Hemal H Patel; Garrett J Gross; Judy R Kersten; Paul S Pagel; David C Warltier Journal: Anesthesiology Date: 2003-03 Impact factor: 7.892
Authors: Marcelo A Nobrega; Stewart Fleming; Richard J Roman; Masahide Shiozawa; Nancy Schlick; Jozef Lazar; Howard J Jacob Journal: Diabetes Date: 2004-03 Impact factor: 9.461
Authors: Filip Sedlic; Maria Y Muravyeva; Ana Sepac; Marija Sedlic; Anna Marie Williams; Meiying Yang; Xiaowen Bai; Zeljko J Bosnjak Journal: J Cell Physiol Date: 2016-06-21 Impact factor: 6.384
Authors: Phing-How Lou; Eliana Lucchinetti; Liyan Zhang; Andreas Affolter; Manoj Gandhi; Martin Hersberger; Blair E Warren; Hélène Lemieux; Hany F Sobhi; Alexander S Clanachan; Michael Zaugg Journal: PLoS One Date: 2014-08-15 Impact factor: 3.240
Authors: Bhawana Agarwal; David F Stowe; Ranjan K Dash; Zeljko J Bosnjak; Amadou K S Camara Journal: Front Physiol Date: 2014-09-16 Impact factor: 4.566
Authors: Jake Russell; Eugene F Du Toit; Jason N Peart; Hemal H Patel; John P Headrick Journal: Cardiovasc Diabetol Date: 2017-12-04 Impact factor: 9.951
Authors: Tomo Svaguša; Mislav Martinić; Matea Martinić; Lucija Kovačević; Ana Šepac; Davor Miličić; Joško Bulum; Boris Starčević; Maja Sirotković-Skerlev; Fran Seiwerth; Ana Kulić; Filip Sedlić Journal: Croat Med J Date: 2020-04-30 Impact factor: 1.351